Trial Profile
Darexaban maleate pharmacokinetics and pharmacodynamics under fed and fasting conditions in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2011
Price :
$35
*
At a glance
- Drugs Darexaban (Primary)
- Indications Acute coronary syndromes; Thromboembolism; Venous thrombosis
- Focus Pharmacokinetics
- 20 Feb 2011 New trial record